STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT)/EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 503	$ 24,497	$ (802)	$ 24,198
Balance at the beginning (in shares) at Dec. 31, 2020	5,031,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 550,000 Private Placement units, including over-allotment, net of fair value of warrant liability	$ 55	5,244,195	0	$ 5,244,250
Sale of 550,000 Private Placement units, including over-allotment, net of fair value of warrant liability (in shares)	550,000			550,000
Shares forfeited due to partial exercise of over-allotment	$ (3)	3	0
Shares forfeited due to partial exercise of over-allotment (in shares)	(31,250)
Issuance of representative shares	$ 9	513	0	$ 522
Issuance of representative shares (in shares)	90,000
Remeasurement to shares subject to possible redemption		0	4,611,738	4,611,738
Remeasurement to shares subject to possible redemption				(4,623,099)
Net income (loss)		0	(798,333)	(798,333)
Balance at the end at Dec. 31, 2021	$ 564	5,269,208	(5,410,873)	(141,101)
Balance at the end (in shares) at Dec. 31, 2021	5,640,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Remeasurement to shares subject to possible redemption		1,611,533	0	1,611,533
Remeasurement to shares subject to possible redemption				(963,263)
Net income (loss)		0	991,838	991,838
Balance at the end at Dec. 31, 2022	$ 564	$ 3,657,675	$ (4,419,035)	$ (760,796)
Balance at the end (in shares) at Dec. 31, 2022	5,640,000